FrancophonIA/ELRC3.0 huggingface dataset:
English: There is no safety or efficacy information on the use of ribavirin with other forms of interferon (i.e. not alfa-2b).
Croatian: Nema podataka o sigurnosti i djelotvornosti ribavirina primijenjenog s drugim oblicima interferona (npr. koji nisu alfa-2b).
English: Within the organ system classes, adverse reactions are listed under headings of frequency using the following categories: very common (≥1/10); common (≥1/100 to <1/10), and uncommon (≥ 1/1,000 to < 1/100).
Croatian: Nuspojave su razvrstane prema organskim sustavima i učestalosti pojavljivanja definiranoj kao vrlo često (≥1/10), često (≥1/100 i <1/10) i manje često (≥1/1000 i <1/100).
English: The pharmacokinetics of ribavirin is altered in patients with renal dysfunction due to reduction of apparent clearance in these patients.
Croatian: Farmakokinetika ribavirina izmijenjena je u bolesnika s disfunkcijom bubrega zbog smanjenog prividnog klirensa u tih bolesnika.
English: These include: - Severe psychiatric and central nervous system effects (such as depression, suicidal ideation,
Croatian: One uključuju: - teške psihijatrijske učinke i teške učinke na središnji živčani sustav (poput depresije, suicidalnih misli, pokušaja samoubojstva i agresivnog ponašanja itd.)
English: Standard haematologic tests, blood chemistries (complete blood count [CBC] and differential, platelet count, electrolytes, serum creatinine, liver function tests, uric acid) and pregnancy tests must be conducted in all patients prior to initiating therapy.
Croatian: U svih se bolesnika prije početka liječenja moraju provesti standardne hematološke i biokemijske pretrage (kompletna krvna slika [KKS], diferencijalna krvna slika, broj trombocita, elektroliti, serumski kreatinin, testovi funkcije jetre, uratna kiselina) te testovi na trudnoću.
English: For HCV/HIV co-infected patients receiving ribavirin in combination with peginterferon alfa-2b, other adverse reactions (that were not reported in mono-infected patients) which have been reported in the studies with a frequency > 5 % were: oral candidiasis (14 %), lipodystrophy acquired (13 %), CD4 lymphocytes decreased (8 %), appetite decreased (8 %), gamma-glutamyltransferase increased (9 %), back pain (5 %), blood amylase increased (6 %), blood lactic acid increased (5 %), cytolytic hepatitis (6 %), lipase increased (6 %) and pain in limb (6 %).
Croatian: U bolesnika s istodobnom infekcijom HCV-om i HIV-om koji primaju ribavirin u kombinaciji s peginterferonom alfa-2b, ostale nuspojave (koje nisu bile prijavljene u bolesnika s monoinfekcijom) prijavljene u ispitivanjima s učestalošću od >5% uključivale su: oralnu kandidijazu (14%), stečenu lipodistrofiju (13%), smanjen broj CD4 limfocita (8%), smanjen tek (8%), povišene vrijednosti gama-glutamiltransferaze (9%), bol u leđima (5%), povišene vrijednosti amilaze u krvi (6%), povišene vrijednosti mliječne kiseline u krvi (5%), citolitički hepatitis (6%), povišene vrijednosti lipaze (6%) i bol u udovima (6%).
English: No data are available regarding dose modification for paediatric patients with renal impairment (see sections 4.2 and 5.2).
Croatian: Nema podataka o prilagodbi doze u pedijatrijskih bolesnika s oštećenjem funkcije bubrega (vidjeti dijelove 4.2 i 5.2).
English: P1.5/R Ribavirin (800 mg) + peginterferon alfa-2b (1.5 micrograms/kg) P0.5/R Ribavirin (1,000/1,200 mg) + peginterferon alfa-2b (1.5 to 0.5 microgram/kg) I/R
Croatian: P 1,5/R ribavirin (800 mg) + peginterferon alfa-2b (1,5 mikrograma/kg) P 0,5/R ribavirin (1000/1200 mg) + peginterferon alfa-2b (1,5 do 0,5 mikrograma/kg) I/R
English: Please refer to the corresponding SmPC of medicinal products used in combination with ribavirin as some combination regimens do not adhere to the ribavirin dosing guidance provided in Table 1.
Croatian: Molimo pročitajte odgovarajuće Sažetke opisa svojstava lijeka za lijekove koji se primjenjuju u kombinaciji s ribavirinom, jer neki režimi kombiniranog liječenja ne podliježu smjernicama za doziranje ribavirina navedenim u Tablici 1.
English: No pharmacokinetic interactions were noted between ribavirin and peginterferon alfa-2b or interferon alfa-2b in a multiple-dose pharmacokinetic study.
Croatian: Nisu primijećene farmakokinetičke interakcije između ribavirina i peginterferona alfa-2b ili interferona alfa-2b u farmakokinetičkom ispitivanju s primjenom višestrukih doza.
English: Malformations of the skull, palate, eye, jaw, limbs, skeleton and gastrointestinal tract were noted.
Croatian: Zabilježene su malformacije lubanje, nepca, oka, čeljusti, udova, kostura i gastrointestinalnog trakta.
English: Diabetes mellitus, hypertriglyceridemia*
Croatian: šećerna bolest, hipertrigliceridemija*
English: The use of ribavirin in combination treatment with interferon alfa-2b was evaluated in a number of clinical trials.
Croatian: Primjena ribavirina u kombinaciji s interferonom alfa-2b ocjenjivala se u nekoliko kliničkih ispitivanja.
English: Infections and infestations
Croatian: Infekcije i infestacije vrlo često:
English: Tabulated list of adverse reactions for adults
Croatian: Tablični prikaz nuspojava u odraslih
English: Mean (% CV) multiple-dose pharmacokinetic parameters for interferon alfa-2b and ribavirin when administered to paediatric patients with chronic hepatitis C
Croatian: Tablica 10 Srednje vrijednosti (% CV) farmakokinetičkih parametara za interferon alfa-2b i ribavirin primijenjene u pedijatrijskih bolesnika s kroničnim hepatitisom C
English: Pigmentation disorder, dermatitis atopic, skin exfoliation
Croatian: poremećaj pigmentacije, atopički dermatitis, ljuštenje kože
English: When deciding not to defer treatment until adulthood, it is important to consider that the combination therapy induced a growth inhibition, that may be irreversible in some patients.
Croatian: Prilikom donošenja odluke o tome da se liječenje neće odgoditi do odrasle dobi, važno je uzeti u obzir da je kombinirana terapija dovela do inhibicije rasta, koji u nekih bolesnika može biti ireverzibilan.
English: The safety of ribavirin is evaluated from data from four clinical trials in patients with no previous exposure to interferon (interferon-naïve patients): two trials studied ribavirin in combination with interferon alfa-2b, two trials studied ribavirin in combination with peginterferon alfa-2b.
Croatian: Sigurnost ribavirin tableta procijenjena je na temelju podataka prikupljenih u četiri klinička ispitivanja u bolesnika koji prethodno nisu bili liječeni interferonom: u dva ispitivanja proučavao se ribavirin u kombinaciji s interferonom alfa-2b, a u preostala dva ispitivanja u kombinaciji s peginterferonom alfa-2b.
English: The attempt to self-harm has also been reported in adults, children, and adolescents.
Croatian: U odraslih bolesnika, djece i adolescenata prijavljen je i pokušaj samoozljeđivanja.
English: Children and adolescents 3 to 16 years of age with compensated chronic hepatitis C and detectable HCV-RNA (assessed by a central laboratory using a research-based RT-PCR assay) were enrolled in two multicentre trials and received ribavirin 15 mg/kg per day plus interferon alfa-2b 3 MIU/m2 3
Croatian: Djeca i adolescenti u dobi od 3 do 16 godina s kompenziranim kroničnim hepatitisom C i mjerljivom razinom HCV-RNK (procijenio centralni laboratorij korištenjem istraživanja zasnovanog na RT-PCR testu) uključeni su u dva multicentrična ispitivanja u kojima su godinu dana primali ribavirin u dozi od 15 mg/kg na dan i interferon alfa-2b u dozi od 3 MIU/m2 triput na tjedan tijekom 1 godine, nakon čega su praćeni 6 mjeseci.
English: This medicine in combination with peginterferon alfa-2b or interferon alfa-2b may also cause: dark, cloudy or abnormally coloured urine, difficulty breathing, changes in the way your heart beats, chest pain, pain down left arm, jaw pain, loss of consciousness, loss of use, drooping or loss of power of facial muscles, loss of feeling sensation, loss of vision.
Croatian: Ovaj lijek u kombinaciji s peginterferonom alfa-2b ili interferonom alfa-2b također može prouzročiti: tamnu, zamućenu ili neuobičajeno obojenu mokraću, otežano disanje, promjene srčanog ritma, bol u prsištu, bol duž lijeve ruke, bol u čeljusti, gubitak svijesti, gubitak odnosno smanjenje funkcije ili snage mišića lica, gubitak osjeta, gubitak vida.
English: - Haemoglobinopathies (e.g., thalassemia, sickle-cell anaemia).
Croatian: - Hemoglobinopatije (npr. talasemija, anemija srpastih stanica).
English: decreases in the number of red blood cells (that may cause fatigue, shortness of breath, dizziness), decrease in neutrophils (that make you more susceptible to different infections), decrease in thyroid gland activity (which may make you feel tired, depressed, increase your sensitivity to cold and other symptoms),
Croatian: smanjenje broja crvenih krvnih stanica (koje može uzrokovati umor, nedostatak zraka, omaglicu), smanjenje broja neutrofila (zbog čega možete biti osjetljiviji na razne infekcije), smanjenje aktivnosti štitnjače (zbog čega se možete osjećati umorno, depresivno te biti osjetljiviji na hladnoću ili imati druge simptome),
English: Two large long-term follow-up studies enrolled 1,071 patients and 567 patients after treatment in prior studies with nonpegylated interferon alfa-2b (with or without ribavirin) and pegylated interferon alfa2b (with or without ribavirin), respectively.
Croatian: Dva su velika ispitivanja dugotrajnog praćenja nakon liječenja uključila 1071 bolesnika iz prethodnih ispitivanja s nepegiliranim interferonom alfa-2b (sa ili bez ribavirina) i 567 bolesnika iz ispitivanja s pegiliranim interferonom alfa-2b (sa ili bez ribavirina).
English: There is no safety or efficacy information on the use of ribavirin with pegylated or other forms of interferon (i.e., not alfa-2b).
Croatian: Ne postoje podaci o sigurnosti i djelotvornosti ribavirina primijenjenog s pegiliranim ili drugim oblicima interferona (npr. koji nisu alfa-2b).
English: Ribavirin 15 mg/kg/day interferon alfa-2b 3 MIU/m2 3 times a week
Croatian: Ribavirin 15 mg/kg/dan interferon alfa-2b 3 MIU/m2 triput na tjedan
English: Table 4 provides guidelines for dose modification for patients with renal dysfunction.
Croatian: U Tablici 4 navode se smjernice za prilagodbu doze u bolesnika s disfunkcijom bubrega.
English: Aplastic anaemia*
Croatian: aplastična anemija*
English: hearing or seeing images that are not present, heart attack, panic attack, hypersensitivity reaction to the medication inflammation of pancreas, pain in bone, diabetes mellitus, muscle weakness,
Croatian: opažanje zvukova ili predmeta koji nisu stvarni, srčani udar, napad panike, reakcija preosjetljivosti na lijek, upala gušterače, bol u kostima, šećerna bolest, mišićna slabost.
English: All but one of the paediatric subjects remained sustained virologic responders during long-term follow-up after completion of treatment with interferon alfa-2b plus ribavirin.
Croatian: U svih pedijatrijskih ispitanika osim jednog održan je trajan virološki odgovor za vrijeme dugotrajnog praćenja nakon završetka liječenja interferonom alfa-2b i ribavirinom.
English: Liver function
Croatian: Funkcija jetre
English: No interaction studies have been conducted with ribavirin and other medicinal products, except for peginterferon alfa-2b, interferon alfa-2b and antacids.
Croatian: Nisu provedena ispitivanja interakcija ribavirina s drugim lijekovima osim s peginterferonom alfa-2b, interferonom alfa-2b i antacidima.
English: Oral formulations of ribavirin monotherapy have been investigated as therapy for chronic hepatitis C in several clinical trials.
Croatian: Peroralni oblici ribavirina ispitivani su u nekoliko kliničkih ispitivanja kao monoterapija za kronični hepatitis C.
English: Mitochondrial toxicity and lactic acidosis have been reported in HIV-positive patients receiving NRTI regimen and associated-ribavirin for co-HCV infection (see section 4.4).
Croatian: Mitohondrijska toksičnost i laktacidoza prijavljene su u HIV-pozitivnih bolesnika koji su primali NRTI i dodatnu terapiju ribavirinom zbog istodobne infekcije HCV-om (vidjeti dio 4.4).
English: Hypotension
Croatian: hipotenzija
English: Ribavirin monotherapy must not be used.
Croatian: Ribavirin se ne smije primjenjivati u monoterapiji.
English: Pericardial effusion*, pericarditis*
Croatian: perikardijalni izljev*, perikarditis*
English: Teva Denmark A/S Tlf: +45 44 98 55 11
Croatian: Tlf: +45 44 98 55 11
English: Adult patients with severe renal impairment (creatinine clearance of < 30 mL/minute) and patients with End Stage Renal Disease (ESRD) or on haemodialysis should be administered ribavirin 200 mg/day.
Croatian: U odraslih bolesnika s teškim oštećenjem funkcije bubrega (klirens kreatinina <30 ml/min) i bolesnika u terminalnoj fazi bubrežne bolesti ili na hemodijalizi treba primjenjivati 200 mg lijeka ribavirina na dan.
English: The purpose of the study was to annually evaluate the durability of sustained virologic response (SVR) and assess the impact of continued viral negativity on clinical outcomes for patients who were sustained responders 24 weeks post-treatment with 24 or 48 weeks of peginterferon alfa-2b and ribavirin treatment.
Croatian: Svrha ispitivanja bila je godišnja procjena postojanosti trajnog virološkog odgovora i utjecaja kontinuirano negativnog nalaza virusa na klinički ishod bolesti u bolesnika koji su pokazali trajan odgovor 24 tjedna nakon 24-tjednog ili 48-tjednog liječenja peginterferonom alfa-2b i ribavirinom.
English: Eligible patients for these trials had chronic hepatitis C confirmed by a positive HCVRNA polymerase chain reaction assay (PCR) (> 30 IU/mL), a liver biopsy consistent with a histological diagnosis of chronic hepatitis with no other cause for the chronic hepatitis, and abnormal serum ALT.
Croatian: Bolesnici pogodni za ova ispitivanja imali su kronični hepatitis C potvrđen pozitivnim nalazom HCV-RNK pomoću testa lančane reakcije polimerazom (PCR) (>30 IU/ml), nalazom biopsije jetre koji je odgovarao patohistološkoj dijagnozi kroničnog hepatitisa bez nekog drugog mogućeg uzroka kroničnog hepatitisa i odstupanjem od normalnih vrijednosti ALT-a u serumu.
English: However, response rates in this trial were shown to be dependent also on the dose of ribavirin administered in combination with peginterferon alfa-2b or interferon alfa-2b.
Croatian: Međutim, pokazalo se da je stopa odgovora u ovom ispitivanju ovisio i o dozi ribavirina primijenjenog u kombinaciji s peginterferonom alfa-2b ili interferonom alfa-2b.
English: For use in patients with decompensated cirrhosis, see the corresponding SmPC of the medicinal products used in combination with ribavirin.
Croatian: Za primjenu u bolesnika s dekompenziranom cirozom, pročitajte odgovarajuće Sažetke opisa svojstava lijeka za lijekove koji se primjenjuju u kombinaciji s ribavirinom.
English: Patient weight (kg)
Croatian: adolescenta (kg)
English: Co-infected patients with advanced liver disease receiving cART may be at increased risk of worsening liver function.
Croatian: Bolesnici s istodobnom infekcijom HIV-om i HCV-om koji imaju uznapredovalu bolest jetre i primaju cART mogu imati povećan rizik od pogoršanja funkcije jetre.
English:  2 g/dL decrease in haemoglobin during any 4 week period during treatment (permanent dose reduction)
Croatian: Hemoglobin: bolesnici sa stabilnom srčanom bolešću u anamnezi pad vrijednosti hemoglobina za 2 g/dl tijekom bilo kojeg 4-tjednog razdoblja za vrijeme liječenja (trajno smanjenje doze)
English: Uric acid may increase with ribavirin due to haemolysis; therefore, the potential for development of gout must be carefully monitored in pre-disposed patients.
Croatian: Zbog hemolize uslijed uzimanja ribavirina može doći do povišenja koncentracije uratne kiseline, stoga se bolesnike s predispozicijom mora pažljivo promatrati zbog mogućeg razvoja gihta.
English: Cardiac disorders
Croatian: Kardiovaskularni sustav
English: Hyperthyroidism, virilism
Croatian: hipotireoza hipertireoza, virilizam
English: The use of pegylated alpha interferons and ribavirin concomitantly with azathioprine should be avoided.
Croatian: Treba izbjegavati istodobnu primjenu pegiliranih alfa interferona i ribavirina s azatioprinom.
English: The purpose of the study was to annually evaluate the durability of sustained virologic response (SVR) and assess the impact of continued viral negativity on clinical outcomes for patients who were sustained responders 24 weeks post-treatment of the 48-week interferon alfa-2b and ribavirin treatment.
Croatian: Svrha ispitivanja bila je godišnja procjena postojanosti trajnog virološkog odgovora i utjecaja kontinuirano negativnog nalaza virusa na klinički ishod bolesti u bolesnika koji su pokazali trajan odgovor 24 tjedna nakon 48-tjednog liječenja interferonom alfa-2b i ribavirinom.
English: * Since ribavirin has always been prescribed with an alpha interferon product, and the listed adverse drug reactions included reflecting post-marketing experience do not allow precise quantification of frequency, the frequency reported above is from clinical trials using ribavirin in combination with interferon alfa-2b (pegylated or nonpegylated).
Croatian: * Kako se ribavirin uvijek propisuje u kombinaciji s alfa interferonom te nije moguće točno kvantificirati ili odrediti učestalost navedenih nuspojava prijavljenih nakon stavljanja lijeka u promet, gore prijavljena kategorija učestalosti predstavlja učestalost iz kliničkih ispitivanja u kojima se ribavirin primjenjivao u kombinaciji s interferonom alfa-2b (pegiliranim ili nepegiliranim).
English: Enuresis, micturition disorder, urinary incontinence, proteinuria
Croatian: Poremećaji bubrega i mokraćnog sustava enureza, poremećaj mokrenja, urinarna inkontinencija, proteinurija
English: Reminder: Please read the “Do not take” section of the Package leaflet for the other medicines used in combination before you begin combination treatment with this medicine.
Croatian: Podsjetnik: Molimo pročitajte dio "Nemojte uzimati" u Uputi o lijeku za druge lijekove koji se primjenjuju u kombinaciji s ovim lijekom.
English: Ribavirin Teva Pharma B.V. dose based on body weight when used in combination with interferon alfa-2b or peginterferon alfa-2b in children above 3 years of age and adolescents
Croatian: Doza lijeka Ribavirin Teva Pharma B.V. određena na temelju tjelesne težine kad se kombinira s interferonom alfa-2b ili peginterferonom alfa-2b u djece starije od 3 godine i adolescenata Tjelesna težina djeteta/
English: Combination therapy also decreased the relapse rate.
Croatian: Kombinirano je liječenje također smanjilo stopu relapsa za sve genotipove virusa HCV.
English: Ribavirin Teva Pharma B.V. must not be used by females who are pregnant (see sections 4.3, 4.4 and 5.3).
Croatian: Trudnice ne smiju uzimati Ribavirin Teva Pharma B.V. (vidjeti dijelove 4.3, 4.4 i 5.3).
English: Previous treatment failure patients
Croatian: Prethodno neuspjelo liječenje
English: Upon multiple dosing, ribavirin accumulates extensively in plasma with a six-fold ratio of multiple-dose to single-dose AUC12hr.
Croatian: Nakon primjene višekratnih doza ribavirin se znatno nakuplja u plazmi, pri čemu je AUC12hr nakon višekratnih doza šesterostruko veći nego nakon jedne doze.
English: Ribavirin Teva Pharma B.V. has no or negligible influence on the ability to drive and use machines; however, other medicinal products used in combination may have an effect.
Croatian: Ribavirin Teva Pharma B.V. ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: All
Croatian: Svi
English: Ribavirin Teva Pharma B.V. is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults, children 3-years of age or older and adolescents and must only be used as part of a combination regimen with interferon alfa-2b.
Croatian: Ribavirin Teva Pharma B.V. indiciran je u liječenju kronične infekcije virusom hepatitisa C (HCV) u odraslih, djece u dobi od 3 godine i više te adolescenata, a smije se primjenjivati samo u kombinaciji s interferonom alfa-2b.
English: An increase in uric acid and indirect bilirubin values associated with haemolysis were also observed in some patients.
Croatian: U nekih su bolesnika primijećene i povišene vrijednosti uratne kiseline i indirektnog bilirubina povezane s hemolizom.
English: CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Croatian: UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU PRIMJENU
English: TEVA UK Ltd Brampton Road
Croatian: Brampton Road
English: • Men
Croatian: • Muškarci:
English: Hepatic decompensation in HCV/HIV co-infected patients with advanced cirrhosis:
Croatian: Dekompenzacija jetre u bolesnika s istodobnom infekcijom HCV-om i HIV-om i uznapredovalom cirozom:
English: Table 5 Adverse reactions reported during clinical trials or following the marketing use of ribavirin with pegylated interferon alfa-2b or interferon alfa-2b
Croatian: Tablica 5 Nuspojave prijavljene u kliničkim ispitivanjima ili nakon stavljanja u promet ribavirina s pegiliranim interferonom alfa-2b ili interferonom alfa-2b
English: Tablet core; Calcium hydrogen phosphate anhydrous, croscarmellose sodium, povidone, magnesium stearate.
Croatian: Jezgra tablete: bezvodni kalcijev hidrogenfosfat, umrežena karmelozanatij, povidon, magnezijev stearat.
English: At the end of 24 weeks post-treatment follow-up, mean decrease from baseline in weight and height percentiles were still 3 percentiles and 7 percentiles, respectively, and 20% of the children continued to have inhibited growth (growth velocity < 3rd percentile).
Croatian: Na kraju 24-tjednog praćenja nakon završetka liječenja srednje vrijednosti su još uvijek bile smanjene u odnosu na početak ispitivanja za prosječno 3 percentila na krivulji težine te za prosječno 7 percentila na krivulji rasta, dok je 20% djece i dalje imalo usporen rast (brzina rasta <3. percentile).
English: Some data suggest that HIV/HCV co-infected patients receiving abacavir-containing ART may be at risk of a lower response rate to pegylated interferon/ribavirin therapy.
Croatian: Neki podaci pokazuju da bi u bolesnika istodobno zaraženih HIV-om i HCV-om koji primaju abakavir u sklopu antiretrovirusne terapije mogao postojati rizik od slabije stope odgovora na kombiniranu terapiju pegiliranim interferonom i ribavirinom.
English: Male: impotence, prostatitis, erectile dysfunction, Sexual dysfunction (not specified)*
Croatian: Muškarci: impotencija, prostatitis, erektilna disfunkcija.
English: Both the Metavir score and Ishak grade decreased among subjects treated with ribavirin in combination with peginterferon alfa-2b.
Croatian: I Metavir izračun i stupanj po Ishaku smanjili su se u ispitanika liječenih ribavirinom u kombinaciji s peginterferonom alfa-2b.
English: 4 x 200 mg tabletsb Refer to adult dose recommendation a: 1 morning, 2 evening b: 2 morning, 2 evening
Croatian: Vidjeti preporuke za doziranje u odraslih a: 1 ujutro, 2 uvečer b: 2 ujutro, 2 uvečer
English: A certain number of adverse reactions, generally attributed to interferon therapy but that have been reported in the context of hepatitis C therapy (in combination with ribavirin) are also listed for reference in Table 5.
Croatian: U Tablici 5 je za informaciju naveden i određen broj nuspojava koje se općenito pripisuju interferonskoj terapiji, ali su prijavljene u sklopu liječenja hepatitisa C (u kombinaciji s ribavirinom).
English: • Ribavirin (1,000/1,200 mg/day) + interferon alfa-2b (3 MIU three times a week) (n = 505).
Croatian: • Ribavirin (1000/1200 mg/dan) + interferon alfa-2b (3 MIU triput na tjedan) (n=505).
English: Ribavirin Teva Pharma B.V. 200 mg film-coated tablets are light-pink to pink, (debossed with “93” on one side and “7232” on the other).
Croatian: 200 mg filmom obložene tablete su svijetlo ružičaste do ružičaste (s utisnutim "93" na jednoj strani i "7232" na drugoj).
English: • have another liver problem in addition to hepatitis C infection.
Croatian: • uz infekciju virusom hepatitisa C imate još neku jetrenu tegobu.